Page 98 - ICD-AR22-English

Notes to the Separate Financial Statements
FOR THE YEAR ENDED 31 DECEMBER 2022
Opening balance 1,536,402,435
Additions 398,761,597
Redemptions (367,386,246)
1,357,096,279
1,433,050,000
(1,234,643,627)
(1,278,593)
-
-
(19,157,271)
1,335,647 853,380,005
544,100,949
138,921,481
95,356,675
72,953,990
844,099,858
523,991,912
31 December 2022 USD
31 December 2021 USD
Exchange loss
Unrealised fair value loss through equity Amortised premium
Fair value loss through separate income statement Reversal / (charge) for impairment
Financial institutions Governments Others
AAA
AA+ to AA- A+toA- BBB+ or lower
(1,860,951)
(31,341,263)
(7,382,445)
-
(2,692,741) 1,004,677,609
366,347,981
153,474,796
119,329,668
76,193,259
712,979,527
615,997,932
1,524,500,386
1,536,402,435
1,524,500,386
1,536,402,435
1,524,500,386
1,536,402,435
Sukuk investments included an amount of USD 119,466,546 (31 December 2021: USD 125,357,109) invested in Sukuk issued by IsDB and IILM, over which the Corporation earned profit of USD 2,027,268 (31 December 2021: USD 1,197,792)
Income from sukuk investments recognised during the year are as follows:
Coupon income
Premium amortization
Realized gain
Fair value loss through income statement
44,969,138
(7,382,445)
(735,107)
-
39,399,200
-
1,522,306
(19,157,271)
31 December 2022 USD
31 December 2021 USD
Total income
36,851,586
21,764,235
96 ICD ANNUAL REPORT 2022